sixty-four patients with hairy-cell leukemia ( hcl ) ( 61 had undergone prior splenectomy ) were treated with alpha-2 interferon ( intron a , schering corp , kenilworth , nj ) subcutaneously three times per week at a dosage of 2 x 10 ( 6 ) u/m2 .
C0023443
hairy-cell leukemia
C0021734
alpha-2 interferon